Position in ILMN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$243,438
-$57,996 QoQ
Shares Held
1,975
-37.8% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2022
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ILMN Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Graham Capital Management, L.P. holds $10,662,805 across 8 Diagnostics & Research names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NTRA |
Natera, Inc.
|
25,748 | $6,989,294 | |
| 2 | DHR |
Danaher Corp /De/
|
10,612 | $2,021,373 | |
| 3 | IDXX |
Idexx Laboratories Inc /De
|
879 | $462,740 | |
| 4 | MEDP |
Medpace Holdings, Inc.
|
839 | $444,326 | |
| 5 | CRL |
Charles River Laboratories International, Inc.
|
1,454 | $329,752 | |
| 6 | IQV |
Iqvia Holdings Inc.
|
1,121 | $216,599 | |
| 7 | MYGN |
Myriad Genetics Inc
|
28,804 | $164,470 | |
| 8 | OPK |
Opko Health, Inc.
|
22,834 | $34,251 |
All Filings in ILMN
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $243,438 | 1,975 | Shares | Sole | 2026-05-15 | |
| 2025-09-30 | $301,434 | 3,174 | Shares | Sole | 2025-11-14 | |
| 2025-03-31 | $1,025,628 | 12,927 | Shares | Sole | 2025-05-15 | |
| 2024-09-30 | $271,904 | 2,085 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $365,434 | 3,501 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $1,418,241 | 10,328 | Shares | Sole | 2024-05-15 | |
| 2022-12-31 | $2,610,806 | 12,912 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $640,863 | 3,359 | Shares | Sole | 2022-11-14 | |
| No filing history on record for this holder in this stock. | ||||||